Top 8 rebinynpro.com competitors & alternatives
[Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated HCP Site HCP site for Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated, a treatment for hemophilia from Novo Nordisk. Read Important Safety & Prescribing Info.]
rebinynpro.com competitors and alternatives
Top 8 rebinynpro.com competitors and alternatives are ranked by similar search terms, traffic and worth.
rebinynpro.com's top 5 competitors are: novosevenrt.com with 0 daily traffic and 6,900 estimated worth, mynovosecure.com with 0 daily traffic and 1,900 estimated worth, hemob.org with 0 daily traffic and 0 estimated worth, novoeight.com with 0 daily traffic and 0 estimated worth, rebinyn.com with 0 daily traffic and 0 estimated worth.
novosevenrt.com
Official Patient Website for NovoSeven® RT (coagulation Factor VIIa, recombinant)
NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medication used to treat bleeding in hemophilia A or B with inhibitors, congenital FVII deficiency, and Glanzmann's thrombasthenia when platelets don't work, and adults with acquired hemophilia. See Safety Information and Prescribing Information.
Daily Traffic: 0
Website Worth: $ 6,900
mynovosecure.com
Savings & Support Resource for Bleeding Disorders | NovoCare®
Discover innovative cybersecurity and security solutions with MyNovosecure. Protect your business with our expert services and cutting-edge technology.
Daily Traffic: 0
Website Worth: $ 1,900
hemob.org
The Coalition for Hemophilia B
The Coalition for Hemophilia B strives to make quality of life the focal
point of treatment for individuals with Hemophilia B in the 21st century.
Daily Traffic: 0
Website Worth: $ 0
novoeight.com
Novoeight® (Antihemophilic Factor [Recombinant]) | Novoeight® for Patients
Novoeight® (Antihemophilic Factor [Recombinant]) | Novoeight® for Patients
Daily Traffic: 0
Website Worth: $ 0
rebinyn.com
Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
Rebinyn® is an injectable treatment used to replace clotting Factor IX in people with hemophilia B. It can be used as routine prophylaxis to reduce the number of bleeding episodes. Read important safety & prescribing info.
Daily Traffic: 0
Website Worth: $ 0
novosevenrtpro.com
NovoSeven® RT (coagulation Factor VIIa, recombinant) for HCP
NovoSeven® RT (coagulation Factor VIIa, recombinant) is a drug focused on effective bleed control treatment for your patients with hemophilia A or B with inhibitors, congenital Factor VII deficiency, Glanzmann's thrombasthenia with refractoriness to platelets, and acquired hemophilia. See Boxed Warning and Prescribing Info.
Daily Traffic: 0
Website Worth: $ 0
novoeightpro.com
Novoeight® (Antihemophilic Factor [Recombinant]) | HCP Website
Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, among other indications. See Prescribing Info.
Daily Traffic: 0
Website Worth: $ 0
tretten.com
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | Home
Learn about treatment with Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]), the only recombinant therapy for congenital factor XIII A-subunit deficiency.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like rebinynpro.com